Close

Meridian Life Science Whitepapers

Benefits of multiplex testing for the differential diagnosis of COVID-19, Flu, and RSV in a busy flu season 

This year’s winter season is anticipated to be a difficult one as experts warn of a “twindemic” with surges of both influenza and COVID-19 expected. The drop in seasonal temperature combined with people staying indoors traditionally creates a sharp increase in transmission of winter respiratory viruses such as flu and RSV. However, last year due to social distancing and mask-wearing policies, the flu season experienced a reprieve with historically low rates of influenza recorded. In contrast, this year as communities re-open and many of those policies are relaxed, experts predict large increases in transmission for COVID-19 and flu simultaneously. For a medical system that has already been under tremendous strain for the past 18 months, this news is concerning. Using tools such as multiplexing assays for flu, COVID, and RSV to diagnose and treat patients faster and more effectively becomes a necessary next step.

Click here to view the Whitepaper

迈迪安提供全面解决方案

迈迪安为诊断制造商提供完整的解决方案,包括超过3000种抗原和抗体,涵盖500多种疾病,以及广泛的专业qPCR/RT-qPCR预混液和分子酶,所有产品均在符合ISO13485质控要求下生产。

查看所有产品
Meridian搜索

与我们的专业团队联系

想了解更多迈迪安免疫和分子产品信息?欢迎与我们联系


By submitting your information in this form, you agree that your personal information may be stored and processed in any country where we have facilities or service providers, and by using our “Contact Us” page you agree to the transfer of information to countries outside of your country of residence, including to the United States, which may provide for different data protection rules than in your country. The information you submit will be governed by our Privacy Statement.
Welcome to
logo blue

Please select your country to continue

Continue
EN